Choksi Laboratories Limited announced that the United States Food & Drug Administration (USFDA) conducted an inspection at its central laboratory in Indore. The inspection took place between August 17, 2026, and August 20, 2026. Following the inspection, the company received 4 observations, which it is actively addressing. Choksi Laboratories reaffirms its commitment to full compliance with USFDA regulations and maintaining high quality standards.
USFDA Inspection at Indore Laboratory
Choksi Laboratories Limited has informed stakeholders about an inspection conducted by the United States Food & Drug Administration (USFDA) at its central laboratory facility located in Indore. The inspection period was from August 17, 2026, to August 20, 2026.
Inspection Outcome and Next Steps
Upon conclusion of the inspection, the company was issued 4 observations. Choksi Laboratories is currently working on addressing these observations comprehensively and plans to submit a response to the USFDA within the stipulated timeframe. The company emphasized its ongoing commitment to adhering strictly to USFDA regulations and upholding the highest standards of quality and regulatory compliance at all times.
Source: BSE
